Debugging California: Fighting mosquitoes with mosquitoes
On Jun. 4, 2026, a program called Debug—run by Google’s health research arm—has applied to the EPA to…
-
-
Debug by Google expands Singapore site to accelerate AI and automation inglobal fight against mosquito-borne diseases
On May 12, 2026, Debug, a Google initiative to reduce mosquito-borne diseases,announced the expansion of its research and…
-
MAP-Xing malaria protein complexes
On Dec. 12, 2025, an international research team headed by scientists from Nanyang Technological University, Singapore and the…
-
Clogged ‘drains’ in the brain a likely early-warning sign of Alzheimer’s disease
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
-
GOOD Meat received full approval in the U.S. for cultivated meat
On Jun. 21, 2023, GOOD Meat, the cultivated meat division of food technology company Eat Just, Inc., announced…
-
FAO and WHO released report identifying food safety hazards of cell-based food
On Apr. 6, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
-
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
-
Novavax’s COVID-19 vaccine Nuvaxovid arrived in Singapore
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 heroes & Remembrance
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
-
3CL protease inhibitor NLC-001 added to COVID-19-focused joint venture between Todos Medical and NLC Pharma
On Sept. 17, 2020, Todos Medical announced that NLC Pharma had added the dietary supplement NLC-001 to its…
-
Todos Medical announced $23,760,000 contract for COVID-19 PCR testing equipment & supplies with Wisconsin-based laboratory
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
-
Pathnova Laboratories announced partnership to commercialize Todos Medicals COVID-19 and breast cancer tests in Singapore
On Aug. 3, 2020, Todos Medical announced a partnership with PATHNOVA, a Singapore-based clinical laboratory, for the Company’s…
-
Todos Medical announced cross-distribution agreement with L1 Systems for ventilators and COVID testing
On May 26, 2020, Todos Medical announced that it had entered into a cross-distribution agreement with L1 Systems, Ltd., a…
-
Todos Medical announced first commercial sale of COVID-19 antibody tests
On May 18, 2020, Todos Medical announced its first commercial sale of COVID-19 tests. The sale was made…
-
Duke-NUS, GenScript and A*STAR launched first-in-the-world SARS-CoV-2 serology test
On May 15, 2020, Duke-NUS Medical School, GenScript Biotech, and the Diagnostics Development Hub at Singapore’s Agency for…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
-
Singapore researchers use NanoString’s nCounter to rapidly profile response of immune system to SARS-CoV-2 virus
On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene…
-
Researchers unlock genetic code of cancer-causing liver fluke parasite
On Sept. 10, 2014, an international team of scientists from Singapore, Thailand, China and Australia announced that they…
